Royalty Pharma
RPRX
HK$244.04
Share price
0.75%
Change (1 day)
4.30%
Change (1 year)
Categories
Earnings for Royalty Pharma (RPRX)
Earnings in 2024 (TTM): HK$12.10 Billion
According to Royalty Pharma's latest financial reports the company's current earnings are HK$2.26 Billion. a decrease over its 2023 earnings that were of HK$14.68 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Royalty Pharma from 2019 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | HK$12.10 B | -17.54% |
| 2023 | HK$14.68 B | 351.47% |
| 2022 | HK$3.25 B | -70.3% |
| 2021 | HK$10.94 B | -24.3% |
| 2020 | HK$14.46 B | -31.9% |
| 2019 | HK$21.24 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -HK$0.18 Billion | -101.43% | 🇺🇸 USA |
 | HK$54.56 B | 350.61% | 🇺🇸 USA |
 | HK$98.66 B | 714.77% | 🇺🇸 USA |